Literature DB >> 11244588

[Proximal bile duct cholangiocarcinomas].

M C Blanchet1, C Ducerf, L Benoit, J P Gérard, J Baulieux.   

Abstract

AIM: The aim of this retrospective study was to report a series of 12 patients with hilar cholangiocarcinoma treated by curative resection. PATIENTS AND METHODS: Between 1980 and 1998, curative resection was performed in 12 patients out of 33 patients with a Klatskin's tumor. Preoperative biliary drainage was performed in 6 cases. Resection was limited to the extrahepatic bile duct in one case only. Resection was extended to the liver in 11 cases including segmentectomy I (n = 9), left hepatectomy (n = 7), right hepatectomy (n = 3) and segmentectomy IV (n = 1). Postoperative brachytherapy was performed in 3 patients combined with conventional radiotherapy. Conventional radiotherapy irradiation was performed in 2 patients and was associated with chemotherapy in 1 patient.
RESULTS: There was no postoperative mortality. Postoperative follow-up was uneventful in 5 patients. Actuarial survival rate at 1, 2, 3, and 5 years was 81, 57, 28 and 28%, respectively. Prolonged survivals (88 and 114 months) were observed.
CONCLUSION: Hilar cholangiocarcinomas have a poor prognosis. Curative resections are usually performed with major liver resections. RM cholangiography is now the most efficient examination for selection of surgical indications and choice of the best strategy. Long-term survival can be obtained with curative surgery. Adjuvant treatment has to be assessed by controlled trials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11244588     DOI: 10.1016/s0003-3944(00)00015-8

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  2 in total

1.  Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma.

Authors:  Ping He; Jin-Sen Shi; Wu-Ke Chen; Zuo-Ren Wang; Hong Ren; Hua Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  [Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].

Authors:  Ibrahima Ka; Magatte Faye; Papa Saloum Diop; Amadou Bocar Niang Aliou Coly Faye; Jean Marc Ndoye; Babacar Fall
Journal:  Pan Afr Med J       Date:  2018-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.